Researchers find higher doses of hydroxychloroquine, azithromycin increase COVID patient survival by 200 percent | One America News Network | oann.com

Researchers in New Jersey discover treating patients with higher levels of hydroxychloroquine increases COVID patient survival by up to 200 percent. One America’s Pearson Sharp has more.

Source: Researchers find higher doses of hydroxychloroquine, azithromycin increase COVID patient survival by 200 percent